NCT00003633 Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer Status UNKNOWN Phase PHASE1
NCT00003626 Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy Status COMPLETED Phase PHASE2
NCT00003622 Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy Status WITHDRAWN Phase PHASE2
NCT00003614 Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003607 Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer Status COMPLETED Phase PHASE3
NCT00003516 Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Status TERMINATED Phase PHASE2
NCT00003400 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003394 Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00003391 Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE1
NCT00003343 Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00003329 Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer Status COMPLETED Phase N/A
NCT00003307 Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003290 Radiation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT00003259 Vinorelbine in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003256 Flavopiridol in Treating Patients With Recurrent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003238 Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00003232 Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE3